Trial Profile
A study investigating infection incidences associated with alemtuzumab in patients with renal transplants
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Oct 2015
Price :
$35
*
At a glance
- Drugs Alemtuzumab (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions
- 16 Oct 2015 New trial record